mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.7 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.7 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |